Immix Biopharma, Inc. — Director's Dealing 2021

Dec 16, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immix Biopharma, Inc. (IMMX)
CIK: 0001873835
Period of Report: 2021-12-15

Reporting Person: BUCHAN MELISSA JANE (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options (right to purchase)	$1.86	2031-06-30	Common stock (30000)		Direct

Footnotes

F1: On June 30, 2021, the Registrant issued the Reporting Person options to purchase up to 30,000 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on June 30, 2021, subject to the Reporting Person's continued service with the Registrant.